Managing Intellectual Property writes, “Cannabis companies in the US need to stay abreast of regulatory developments when taking advantage of trade secret laws, especially while the industry is still in its infancy, say lawyers. The fact that cannabis is illegal on a federal level has resulted in a complicated IP landscape in the US. Cannabis companies are unable to obtain federal trademark protection for cannabis products, and a lack of accessible prior art is leading to overly broad patents being granted.”

Director Pauline M. Pelletier was quoted in the article “Cannabis Companies Reveal Trade Secret Conundrums,” published by Managing Intellectual Property.